by EpicentRx | Jun 7, 2023 | 2023, Press Releases
Company details follow-on Phase 2b study design in head and neck cancer for its lead small molecule candidate, RRx-001 Company also presented positive first-in-human data from its TGF-β trap vector, AdAPT-001 TORREY PINES, Calif., June 2, 2023 /PRNewswire/ —...
by EpicentRx | Jun 7, 2023 | Blog
The art career of Pablo Picasso is known for two periods: the “Blue Period” in which he primarily used colder shades of blue and blue-green, and the “Rose Period” where he switched to warmer pink and orange colors. Not to compare ourselves even remotely with one of...
by EpicentRx | May 18, 2023 | Blog
We just watched the extraordinary Michael J. Fox documentary, Still, on Apple TV by Davis Guggenheim. Of the many adjectives that we might use to describe the Fox-narrated documentary based on his memoirs such as inspiring, uplifting, poignant, touching, revealing,...
